Literature DB >> 24112168

Prevalence of juvenile fibromyalgia syndrome in an urban population of Turkish adolescents: impact on depressive symptoms, quality of life and school performance.

Yunus Durmaz1, Gamze Alayli, Sevgi Canbaz, Yeliz Zahiroglu, Ayhan Bilgici, Ilker Ilhanli, Omer Kuru.   

Abstract

BACKGROUND: Juvenile Fibromyalgia Syndrome (JFMS) is a chronic health condition characterized by widespread musculoskeletal pain and multiple tender points (TP). The objective of this study was to determine the prevalence of JFMS in the urban population of Samsun and to determine the impact of JFMS on depression symptoms, school performance and quality of life (QOL).
METHODS: A cross-sectional study was conducted in 1109 children (mean age (14.8 ± 2.0) years old). A questionnaire was applied to the children and a medical examination including TP was performed. Yunus and Masi's criteria were used for diagnosis of JFMS. The children with JFMS were compared with an age and sex matched non-JFMS group. Depression was assessed with Children's Depression Inventory (CDI) and QOL was evaluated with Pediatric Quality of Life Inventory 4.0 (PedsQL4.0).
RESULTS: Sixty-one (5.5%) (13 boys and 48 girls) of 1109 children met the diagnostic criteria of JFMS. While PedsQL scores of children with JFMS were lower than the non-JFMS group for physical, emotional, social, school functioning and total score (P = 0.001), CDI total score was higher in the JFMS group than in the non-JFMS group (P = 0.001). The JFMS group reported more school absences (P = 0.001) and the average school grade was lower in the JFMS group than in the non-JFMS group (P = 0.03).
CONCLUSION: The prevalence of JFMS is high in school age children. Since JFMS is a common problem of childhood, early diagnosis and identification of the disorder and more comprehensive and successful treatment approaches with appropriate psychological assistance may prevent more complex and severe problems in adulthood.

Entities:  

Mesh:

Year:  2013        PMID: 24112168

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  9 in total

Review 1.  Prevalence of fibromyalgia in general population and patients, a systematic review and meta-analysis.

Authors:  Fatemeh Heidari; Mahdi Afshari; Mahmood Moosazadeh
Journal:  Rheumatol Int       Date:  2017-04-26       Impact factor: 2.631

Review 2.  [Definition, diagnostics and therapy of chronic widespread pain and the (so-called) fibromyalgia syndrome in children and adolescents : Updated guidelines 2017].

Authors:  N Draheim; F Ebinger; E Schnöbel-Müller; B Wolf; W Häuser
Journal:  Schmerz       Date:  2017-06       Impact factor: 1.107

3.  Rheumatoid arthritis activity scores in patients with and without fibromyalgia syndrome.

Authors:  Yunus Durmaz; Ilker Ilhanli
Journal:  Ann Saudi Med       Date:  2021-08-22       Impact factor: 1.526

Review 4.  VOSviewer-Based Bibliometric Network Analysis for Evaluating Research on Juvenile Primary Fibromyalgia Syndrome (JPFS).

Authors:  Alessandro Vittori; Marco Cascella; Marianna Leonardi; Federica Monaco; Davide Nocerino; Arturo Cuomo; Alessandro Ottaiano; Francesco Perri; Ilaria Mascilini; Elisa Francia; Emiliano Petrucci; Franco Marinangeli; Sergio Giuseppe Picardo
Journal:  Children (Basel)       Date:  2022-04-28

5.  Functional limitations in children and adolescents suffering from chronic pain: validation and psychometric properties of the German Functional Disability Inventory (FDI-G).

Authors:  Martin Offenbächer; Niko Kohls; Lynn Walker; Christiane Hermann; Boris Hügle; Natalie Jäger; Matthias Richter; Johannes-Peter Haas
Journal:  Rheumatol Int       Date:  2016-06-04       Impact factor: 2.631

6.  Prevalence of Juvenile Fibromyalgia Syndrome Among Children and Adolescents and its Relationship With Academic Success, Depression and Quality of Life, Çorum Province, Turkey.

Authors:  Ayla Çagliyan TÜrk; Füsun Şahİn
Journal:  Arch Rheumatol       Date:  2019-11-06       Impact factor: 1.472

7.  Preliminary experience using milnacipran in patients with juvenile fibromyalgia: lessons from a clinical trial program.

Authors:  Lesley M Arnold; Lucinda Bateman; Robert H Palmer; Yuhua Lin
Journal:  Pediatr Rheumatol Online J       Date:  2015-06-26       Impact factor: 3.054

Review 8.  Juvenile primary Fibromyalgia Syndrome: epidemiology, etiology, pathogenesis, clinical manifestations and diagnosis.

Authors:  Maya Levy Coles; Rotem Weissmann; Yosef Uziel
Journal:  Pediatr Rheumatol Online J       Date:  2021-03-01       Impact factor: 3.054

9.  Paediatric chronic pain prevalence in low- and middle-income countries: A systematic review and meta-analysis.

Authors:  Zi Wei Liao; Chi Le; J Matthew Kynes; Jonathan A Niconchuk; Emilia Pinto; Heather E Laferriere; Camila B Walters
Journal:  EClinicalMedicine       Date:  2022-02-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.